Found 930 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
MOMENTIS is a prospective, observational, single-arm, multicenter global post-market study designed to collect real-world clinical outcomes in up to 500 subjects who have received the MITRIS RESILIA Mitral Valve, Model 11400M.
The aim of this global Phase III study is to investigate the use of tezepelumab as a treatmentfor patients with EoE. This study will evaluate the efficacy and safety of tezepelumab 210 mgevery 4 weeks (Q4W) and tezepelumab 420 mg Q4W administered subcutaneously (SC) usingan accessorized pre-filled syringe (APFS) versus …
Primary: To determine whether TcMS can reduce the burden of VT in patients with VT storm. Secondary: 1. To determine whether low frequency TcMS or TcMS with TBS is more effective at reducing the burden of VT in patients with VT Storm. 2. To determine the safety of TcMS in …
Primary Objective: a) To measure the proportion of breast cancer patients where Cerianna positron emission tomography (PET)/computed tomography (CT) detection of estrogen receptor (ER) status alters the preexamination intended therapeutic management Secondary Objectives: a) Per subject, to qualitatively assess heterogeneity in tumor Cerianna uptake relative to standard-of-care imaging b) Per …
The purpose of this study is to test the study drug, PC14586 alone and in combination with pembrolizumab in patients with an advanced solid tumor with a TP53 Y220C alteration who have gone through one or more anticancer therapies and are not responding. PC14586 will be tested at different doses …
Please refer to Protocol Section 4.0 (Objectives and endpoints). Please refer to Protocol Section 4.0 (Objectives and endpoints). Please refer to Protocol Section 4.0 (Objectives and endpoints).
Please refer to Protocol Section 5 (Trial Objectives) Please refer to Protocol 6.2.1 (Phase 1 Primary Endpoints) and Protocol Section 6.2.4 (Phase 2 Primary Endpoints) Please refer to Protocol 6.2.2 (Phase 1 Secondary Endpoint) and Protocol Section 6.2.5 (Phase 2 Secondary Endpoints)
Phase 2 trial studying the effect of polatuzumab vedotin, venetoclax, and rituximab and hyaluronidase human in treating patients with mantle cell lymphoma that relapsed or does not respond to treatment (refractory). We would like to rely on Advarra as the IRB of record for this study.
We are developing an objective method for assessing motor and cognitive impairment in adults with SCD and using it to determine how we can understand the impact of SCD on aging especially with respect to cognitive impairment and motor performance in activities of daily living.
This registry is an observational study designed to assess the utilization and effectiveness of LUPKYNIS in patients with lupus nephritis (LN) in the U.S. This registry is intended to benefit and support interests of patients, clinicians, regulatory bodies, payers, and industry by obtaining longitudinal data on LUPKYNIS.
